Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference
November 27, 2017 16:10 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor...
Sucampo Reports Third Quarter 2017 Financial Results
November 01, 2017 06:30 ET | Sucampo Pharmaceuticals Inc
Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date Study Results for VTS-270 for Niemann-Pick Disease Type C1 Published in The Lancet CPP-1X/sulindac Granted...
Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference
September 27, 2017 20:43 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the company will participate in...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 21, 2017 08:25 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel
September 20, 2017 16:15 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 19, 2017 16:15 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wells Fargo Healthcare Conference
August 30, 2017 16:05 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports Second Quarter 2017 Financial Results
August 02, 2017 06:30 ET | Sucampo Pharmaceuticals Inc
Patent Issued for Pipeline Compound VTS-270 for Niemann-Pick Disease Type C1 Diluted EPS Loss of $3.92 Resulting from $186.6M IP R&D Second Quarter Charge Due to Accounting Treatment of Vtesse...
Dr. Karen Smith Joins Sucampo’s Board of Directors
July 18, 2017 16:05 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., July 18, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Karen Smith, M.D., Ph.D., M.B.A.,...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference
June 01, 2017 16:30 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., June 01, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...